Zengkai K. Pan
State Key Laboratory Of Medical Genomics
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Second corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.
Journal: The Journal of clinical investigation
Published: August 17, 2026
Long-term effects of multidisciplinary team recommendations on adult patients with acute myeloid leukemia.
Journal: Bioscience trends
Published: February 08, 2026
Clinical application value of detecting the mutation load of the FLT3-ITD gene before allogeneic hematopoietic stem cell transplantation using PCR-NGS technology
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 05, 2026
Corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.
Journal: The Journal of clinical investigation
Published: November 17, 2025
Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.
Journal: American journal of hematology
Published: October 05, 2025
Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.
Journal: Transplantation and cellular therapy
Published: October 03, 2025
Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.
Journal: Bone marrow transplantation
Published: September 19, 2025
Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies.
Journal: Frontiers in cellular and infection microbiology
Published: August 03, 2025
Anti-thymocyte globulin-resistant CD4+ memory T cells contribute to haplo-fever after allogeneic hematopoietic stem cell transplantation.
Journal: Blood science (Baltimore, Md.)
Published: July 28, 2025
Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 20, 2025
MRD and NK-Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Journal: American journal of hematology
Published: February 14, 2025
Last Updated: 09/26/2026